Gökbuget, N
Kelsh, M
Chia, V
Advani, A
Bassan, R
Dombret, H
Doubek, M
Fielding, A K
Giebel, S
Haddad, V
Hoelzer, D
Holland, C
Ifrah, N
Katz, A
Maniar, T
Martinelli, G
Morgades, M
O'Brien, S
Ribera, J-M
Rowe, J M
Stein, A
Topp, M
Wadleigh, M
Kantarjian, H
Article History
Received: 15 July 2016
Accepted: 28 July 2016
First Online: 23 September 2016
Competing interests
: NG and J-MR have received research support and honoraria from Pfizer and Amgen. AA has received research support from Pfizer and Amgen and honoraria from Pfizer. RB and SG have received honoraria from Amgen. AS has served on speakers’ bureau and advisory boards for Amgen. VC, AK, MK and JS are employees and shareholders of Amgen; VH and TM were employees of Amgen when the study was conducted. The remaining authors declare no competing interests.